Reports
Sale
Global Sleep Apnea Devices Market Share, Size, Growth, Trends: By Diagnosis Method: Polysomnography Devices (PSG), Oximeters, Home Sleep Testing Devices; By Therapeutic Devices: Oxygen Devices, Oral Appliances Therapeutic Devices, Others; By End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Sleep Apnea Devices Market Outlook
The global sleep apnea device market size attained a value of USD 9.6 billion in 2023. The market is anticipated to grow at a CAGR of 6.50% during the forecast period of 2024-2032 to reach a value of USD 17 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Sleep apnea refers to a serious sleep disturbance in which respiration ceases and starts again and again. There are several treatment options for recovering from sleep apnea. The examples include wearing an oral brace, sleep apnea surgery, weight management, posture therapy, and behaviour therapy. Therefore, Hypoglossus nerve stimulation, expiratory airway pressure, positive airway pressure therapy and oral pressure therapy are some of the most common therapies for sleep apnea.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The diagnostic devices for sleep apnea can be divided into:
- Polysomnography Devices (PSG)
- Pulse Oximeters
- Actigraphy Devices
The therapeutic devices available in the industry can be divided into the following:
- Oxygen Devices
- Oral Appliances Therapeutic Devices
- Adaptive Servo Ventilation (ASV) Devices
- Masks and Accessories
Oxygen devices are further segmented into:
- Oxygen Concentrators
- Portable Oxygen Concentrators
- Liquid Portable Oxygen
The EMR report looks into the regional markets of sleep apnea devices like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The increased geriatric population is projected to contribute to the development of obstructive sleep apnea (OSA) as a consequence of rising life expectancy. Higher prevalence of OSA in the geriatric population due to apnea-related comorbidities is anticipated to stimulate the growth of the sleep apnea devices market. Improved awareness, identification of illnesses, patient adherence, and healthcare costs are also expected to accelerate the market growth.
The prevalence of sleep apnea rises with an increased risk of other conditions such as high blood pressure, cardiac disease, diabetes as well as mental disorders, like depression and fear. Awareness of the long-term effects of sleep apnea is expected to fuel the revenue growth of the market over the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global sleep apnea devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Fisher & Paykel Healthcare Limited
- Invacare Corporation
- Natus Medical Incorporated
- Cadwell Industries Inc.
- Vyaire Medical Inc.
- Nihon Kohden Corporation
- Koninklijke Philips N.V.
- ResMed Corp.
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Diagnosis Method |
|
| Breakup by Therapeutic Devices |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Sleep Apnea Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Global Sleep Apnea Device Market Overview
5.1 Global Sleep Apnea Device Market Historical Value (2017-2023)
5.2 Global Sleep Apnea Device Market Forecast Value (2024-2032)
6 Global Sleep Apnea Device Market Landscape
6.1 Global Sleep Apnea Device Developers Landscape
6.1.1 Analysis by Year of Establishment
6.1.2 Analysis by Company Size
6.1.3 Analysis by Region
6.2 Global Sleep Apnea Device Product Landscape
6.2.1 Analysis by Diagnosis Method
6.2.2 Analysis by End User
6.2.3 Analysis by Therapeutic Devices
7 Sleep Apnea Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Cost of Treatment
9 Global Sleep Apnea Device Market Dynamics
9.1 Market Drivers and Constraints
9.2 SWOT Analysis
9.3 Porter’s Five Forces Model
9.4 Key Demand Indicators
9.5 Key Price Indicators
9.6 Industry Events, Initiatives, and Trends
9.7 Value Chain Analysis
10 Global Sleep Apnea Device Market Segmentation
10.1 Global Sleep Apnea Device Market by Diagnosis Method
10.1.1 Market Overview
10.1.2 Polysomnography Devices (PSG)
10.1.2.1 Ambulatory PSG Devices
10.1.2.2 Clinical PSG Devices
10.1.3 Oximeters
10.1.3.1 Fingertip Oximeters
10.1.3.2 Handheld Oximeters
10.1.3.3 Wrist-worn Oximeter
10.1.3.4 Tabletop Oximeter
10.1.4 Home Sleep Testing Devices
10.1.4.1 Actigraphy Devices
10.1.4.2 Others
10.2 Global Sleep Apnea Device Market by Therapeutic Devices
10.2.1 Market Overview
10.2.2 Oxygen Devices
10.2.2.1 Oxygen Concentrators
10.2.2.2 Portable Oxygen Concentrators
10.2.2.3 Liquid Portable Oxygen
10.2.3 Oral Appliances Therapeutic Devices
10.2.4 Adaptive Servo Ventilation (ASV) Devices
10.2.5 Masks and Accessories
10.3 Global Sleep Apnea Device Market by End User
10.3.1 Market Overview
10.3.2 Sleep Laboratories and Hospitals
10.3.3 Clinics
10.3.4 Homecare Settings/Individuals
10.3.5 Others
10.4 Global Sleep Apnea Device Market by Region
10.4.1 Market Overview
10.4.2 North America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Latin America
10.4.6 Middle East and Africa
11 North America Sleep Apnea Device Market
11.1 Market Share by Country
11.2 United States of America
11.3 Canada
12 Europe Sleep Apnea Device Market
12.1 Market Share by Country
12.2 United Kingdom
12.3 Germany
12.4 France
12.5 Italy
12.6 Others
13 Asia Pacific Sleep Apnea Device Market
13.1 Market Share by Country
13.2 China
13.3 Japan
13.4 India
13.5 ASEAN
13.6 Australia
13.7 Others
14 Latin America Sleep Apnea Device Market
14.1 Market Share by Country
14.2 Brazil
14.3 Argentina
14.4 Mexico
14.5 Others
15 Middle East and Africa Sleep Apnea Device Market
15.1 Market Share by Country
15.2 Saudi Arabia
15.3 United Arab Emirates
15.4 Nigeria
15.5 South Africa
15.6 Others
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Grants Analysis
17.1 Analysis by year
17.2 Analysis by Amount Awarded
17.3 Analysis by Issuing Authority
17.4 Analysis by Grant Application
17.5 Analysis by Funding Institute
17.6 Analysis by NIH Departments
17.7 Analysis by Recipient Organization
18 Clinical Trials Analysis
18.1 Analysis by Trial Registration Year
18.2 Analysis by Trial Status
18.3 Analysis by Trial Phase
18.4 Analysis by Therapeutic Area
18.5 Analysis by Geography
19 Funding Analysis
19.1 Analysis by Funding Instances
19.2 Analysis by Type of Funding
19.3 Analysis by Funding Amount
19.4 Analysis by Leading Players
19.5 Analysis by Leading Investors
19.6 Analysis by Geography
20 Partnership and Collaborations Analysis
20.1 Analysis by Partnership Instances
20.2 Analysis by Type of Partnership
20.3 Analysis by Leading Players
20.4 Analysis by Geography
21 Regulatory Framework
21.1 Regulatory Overview
21.1.1 US FDA
21.1.2 EU EMA
21.1.3 INDIA CDSCO
21.1.4 JAPAN PMDA
21.1.5 Others
22 Supplier Landscape
22.1 Fisher & Paykel Healthcare Limited
22.1.1 Financial Analysis
22.1.2 Product Portfolio
22.1.3 Demographic Reach and Achievements
22.1.4 Mergers and Acquisitions
22.1.5 Certifications
22.2 Invacare Corporation
22.2.1 Financial Analysis
22.2.2 Product Portfolio
22.2.3 Demographic Reach and Achievements
22.2.4 Mergers and Acquisitions
22.2.5 Certifications
22.3 Natus Medical Incorporated
22.3.1 Financial Analysis
22.3.2 Product Portfolio
22.3.3 Demographic Reach and Achievements
22.3.4 Mergers and Acquisitions
22.3.5 Certifications
22.4 Cadwell Industries Inc.
22.4.1 Financial Analysis
22.4.2 Product Portfolio
22.4.3 Demographic Reach and Achievements
22.4.4 Mergers and Acquisitions
22.4.5 Certifications
22.5 Vyaire Medical, Inc.
22.5.1 Financial Analysis
22.5.2 Product Portfolio
22.5.3 Demographic Reach and Achievements
22.5.4 Mergers and Acquisitions
22.5.5 Certifications
22.6 Nihon Kohden Corporation
22.6.1 Financial Analysis
22.6.2 Product Portfolio
22.6.3 Demographic Reach and Achievements
22.6.4 Mergers and Acquisitions
22.6.5 Certifications
22.7 Koninklijke Philips N.V.
22.7.1 Financial Analysis
22.7.2 Product Portfolio
22.7.3 Demographic Reach and Achievements
22.7.4 Mergers and Acquisitions
22.7.5 Certifications
22.8 ResMed Corp.
22.8.1 Financial Analysis
22.8.2 Product Portfolio
22.8.3 Demographic Reach and Achievements
22.8.4 Mergers and Acquisitions
22.8.5 Certifications
22.9 Somnomed
22.9.1 Financial Analysis
22.9.2 Product Portfolio
22.9.3 Demographic Reach and Achievements
22.9.4 Mergers and Acquisitions
22.9.5 Certifications
22.10 Compumedics
22.10.1 Financial Analysis
22.10.2 Product Portfolio
22.10.3 Demographic Reach and Achievements
22.10.4 Mergers and Acquisitions
22.10.5 Certifications
22.11 Drive Devilbiss Healthcare
22.11.1 Financial Analysis
22.11.2 Product Portfolio
22.11.3 Demographic Reach and Achievements
22.11.4 Mergers and Acquisitions
22.11.5 Certifications
22.12 Lowenstein Medical Technology Gmbh
22.12.1 Financial Analysis
22.12.2 Product Portfolio
22.12.3 Demographic Reach and Achievements
22.12.4 Mergers and Acquisitions
22.12.5 Certifications
22.13 BMC Medical Co., Ltd.
22.13.1 Financial Analysis
22.13.2 Product Portfolio
22.13.3 Demographic Reach and Achievements
22.13.4 Mergers and Acquisitions
22.13.5 Certifications
23 Global Sleep Apnea Device Market- Distribution Model (Additional Insight)
23.1 Overview
23.2 Potential Distributors
23.3 Key Parameters for Distribution Partner Assessment
24 Key Opinion Leaders (KOL) Insights (Additional Insight)
25 Company Competitiveness Analysis (Additional Insight)
25.1 Very Small Companies
25.2 Small Companies
25.3 Mid-Sized Companies
25.4 Large Companies
25.5 Very Large Companies
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The sleep apnea market was valued at USD 9.6 billion in 2023.
The market is expected to grow at a CAGR of 6.50% from 2024 to 2032 to reach USD a value of USD 17 billion by 2032.
The major drivers of the market include the identification of illnesses, patient adherence, improving healthcare costs, awareness of the long-term effects of sleep apnea, growing usage of oral appliances, increasing number of companies venturing into the sleep apnea market, and large pool of undiagnosed sleep apnea patients.
The increased geriatric population and improved awareness are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The diagnostic devices for sleep apnea are polysomnography devices (PSG), pulse oximeters, and actigraphy devices.
The therapeutic devices available in the industry can be divided into oxygen devices, oral appliances therapeutic devices, adaptive servo ventilation (ASV) devices, and masks and accessories. Oxygen devices are further divided into oxygen concentrators, portable oxygen concentrators and liquid portable oxygen.
The major players in the industry are Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, Invacare Corporation, Natus Medical Incorporated, Resmed, Cadwell Industries Inc., Vyaire Medical, Inc., General Electric Company, and Nihon Kohden Corporation, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER